Look for:

Our offer for

BRISTOL-MYERS SQUIBB CO.


ISIN:
US1101221083
WKN:
110122108

2023/02/03 17:56:31
Price
73.105 USD
Difference 0.46% (0.34)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)141,886 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)73.10 USD (300)
Ask (Ask size)73.11 USD (300)
Open73.21 USD
High73.68 USD
Low72.61 USD
Close (prev. day)72.77 USD
VWAP73.232513 USD
Volume (pcs)3,569,157
Trading volume261,378,962.60
Number of trades35,885
Last size100

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/02/03 17:56:31
Price
73.105 USD
Difference 0.46% (0.34)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)141,886 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)73.10 USD (300)
Ask (Ask size)73.11 USD (300)
Open73.21 USD
High73.68 USD
Low72.61 USD
Close (prev. day)72.77 USD
VWAP73.232513 USD
Volume (pcs)3,569,157
Trading volume261,378,962.60
Number of trades35,885
Last size100

Performance and Risk

6m1Y3Y
Perf (%)-7.51%+16.31%+17.46%
Perf (abs.)-5.41+9.35+9.91
Beta0.270.290.49
Volatility23.8821.4424.21
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)72.226 USD (9,489,120)
Ø price 30 days | Ø volume 30 days (pcs.)72.503 USD (8,113,432)
Ø price 100 days | Ø volume 100 days (pcs.)74.080 USD (9,383,092)
Ø price 250 days | Ø volume 250 days (pcs.)73.614 USD (11,647,360)
YTD High | date75.000 USD (2023/01/24)
YTD Low | date69.800 USD (2023/02/02)
52 Weeks High | date81.435 USD (2022/12/01)
52 Weeks Low | date62.900 USD (2022/02/04)

All listings for BRISTOL-MYERS SQUIBB CO.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/02/0317:3567.63 EUR0.0212
Vienna Stock Exchange2023/02/0317:3267.75 EUR0.002
Tradegate2023/02/0317:5067.57 EUR0.0418
Stuttgart2023/02/0309:4867.09 EUR0.002
SIX Swiss Exchange2019/06/2817:3544.39 CHF0.001
SIX Swiss Exchange2019/07/0305:5545.30 USD0.001
NYSE2023/02/0317:5673.105 USD261.3835,885
Munich2023/02/0308:0166.28 EUR0.001
London Stock Exchange European Trade Reporting2023/02/0317:3072.62 USD0.025
Hanover2023/02/0308:0166.25 EUR0.001
Hamburg2023/02/0308:0066.25 EUR0.001
Frankfurt2023/02/0316:0167.08 EUR0.033
Duesseldorf2023/02/0317:3067.56 EUR0.0010
Berlin2023/02/0308:0166.30 EUR0.001
BX Swiss---0.00-

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=716&ID_TYPE_IMAGE_LOGO=2

Contact Details

BRISTOL MYERS SQUIBB CO.
- -
430 East 29th Street - 10016 New York
Telefon: 1-212-546-4000
Fax: -
E-mail: -

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Company Profile

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Members of Management Board

Deepak BhattMember of Board of Directors
Julia HallerMember of Board of Directors
Karen VousdenMember of Board of Directors
Manuel Hidalgo MedinaMember of Board of Directors
Derica RiceMember of Board of Directors
Gerald StorchMember of Board of Directors
Paula PriceMember of Board of Directors
Peter ArduiniMember of Board of Directors
Phyllis YaleMember of Board of Directors
Theodore SamuelsMember of Board of Directors
Giovanni CaforioChairman of Managing Board
Christopher BoernerMember of Executive Committee
Krisztina NemenyiMember of Executive Committee
Rupert VesseyMember of Executive Committee
Samit HirawatMember of Executive Committee
Teresa FoyMember of Executive Committee
Ann PowellMember of Executive Committee
Cari GallmanMember of Executive Committee
Catalina VargasMember of Executive Committee
Cynthia PiccirilloMember of Executive Committee
David ElkinsMember of Executive Committee
Elizabeth MilyMember of Executive Committee
Estelle Vester-BloklandMember of Executive Committee
Frank IncontreraMember of Executive Committee
Greg MeyersMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer